Praxis Precision Medicines Inc. (PRAX) PT Raised to $575 at Goldman Sachs
Tweet
Share
E-mailGet Alerts PRAX Hot Sheet
Price: $352.48 +0.19%
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
18 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Goldman Sachs analyst Kevin Strang raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $575.00 (from $470.00) while maintaining a Buy rating.
You May Also Be Interested In
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Pharvaris B.V. (PHVS) PT Raised to $65 at Cantor Fitzgerald
- Arcus Biosciences (RCUS) PT Raised to $40 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
